Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2020

01-06-2020 | Computed Tomography | Case Report

Extra Luminal Leiomyosarcoma of Inferior Venacava: a Hepatobiliary Surgeon Perspective

Authors: Narendra Pandit, Laligen Awale, Tek Narayan Yadav, Lokesh Shekher Jaiswal, Shailesh Adhikary

Published in: Journal of Gastrointestinal Cancer | Issue 2/2020

Login to get access

Excerpt

Inferior venacava (IVC) leiomyosarcoma (LMS) is a rare, but most common malignant vascular tumor originating in the smooth muscle of the vein wall [1]. The incidence is 1 per 100,000 cases per annum [2]. The entity was first described in 1871, but successful resection and ligation of IVC was done only in 1951, approximately a decade later [3]. Due to its rarity, the disease poses a unique surgical challenge in diagnosis and management. Frequently, a hepatobiliary surgeon may encounter this rare entity and be unable to differentiate from duodenal gastrointestinal stromal tumor, caudate lobe hepatocellular carcinoma, or paraganglioma [2, 4]. Hence, it requires multidisciplinary planning and management involving surgical oncologists, radiologists, urologists, radiation oncologists, and cardiovascular and hepatobiliary surgeons [5]. Here, we describe a rare case of extra luminal leiomyosarcoma of infra renal IVC managed successfully by focal resection and primary repair. …
Literature
1.
go back to reference Moncayo KE, Vidal-Insua JJ, Troncoso A, García R. Inferior vena cava leiomyosarcoma: preoperative diagnosis and surgical management. Surg Case Rep. 2015;1(1):2–5.CrossRef Moncayo KE, Vidal-Insua JJ, Troncoso A, García R. Inferior vena cava leiomyosarcoma: preoperative diagnosis and surgical management. Surg Case Rep. 2015;1(1):2–5.CrossRef
2.
go back to reference Madhavan S, Junnarkar SP, Koh NWC, Shelat VG. Inferior vena cava leiomyosarcoma in an octogenerian. Ann Hepato-Biliary-Pancreat Surg. 2019;23(3):274–7.CrossRef Madhavan S, Junnarkar SP, Koh NWC, Shelat VG. Inferior vena cava leiomyosarcoma in an octogenerian. Ann Hepato-Biliary-Pancreat Surg. 2019;23(3):274–7.CrossRef
3.
go back to reference Wachtel H, Gupta M, Bartlett EK, Jackson BM, Kelz RR, Karakousis GC, et al. Outcomes after resection of leiomyosarcomas of the inferior vena cava: a pooled data analysis of 377 cases. Surg Oncol. 2015;24(1):21–7.PubMedCrossRef Wachtel H, Gupta M, Bartlett EK, Jackson BM, Kelz RR, Karakousis GC, et al. Outcomes after resection of leiomyosarcomas of the inferior vena cava: a pooled data analysis of 377 cases. Surg Oncol. 2015;24(1):21–7.PubMedCrossRef
4.
go back to reference Chan A, Chok K. A vena caval mass: challenging diagnosis with a rare complication. Lancet Oncol. 2018;19(10):e564.PubMedCrossRef Chan A, Chok K. A vena caval mass: challenging diagnosis with a rare complication. Lancet Oncol. 2018;19(10):e564.PubMedCrossRef
5.
go back to reference Ahmed N, Dedania B, Dharan M. Leiomyosarcoma of the inferior vena cava. Pract Gastroenterol. 2018;42(3):42–4. Ahmed N, Dedania B, Dharan M. Leiomyosarcoma of the inferior vena cava. Pract Gastroenterol. 2018;42(3):42–4.
6.
go back to reference Sulpice L, Rayar M, Levi Sandri GB, de Wailly P, Henno S, Turner K, et al. Leiomyosarcoma of the inferior vena cava. J Chir Viscerale. 2016;153(3):167–71.CrossRef Sulpice L, Rayar M, Levi Sandri GB, de Wailly P, Henno S, Turner K, et al. Leiomyosarcoma of the inferior vena cava. J Chir Viscerale. 2016;153(3):167–71.CrossRef
7.
8.
go back to reference Jiang H, Wang YX, Li B, Jiang YY, Miao C, Li, et al. Surgical management of leiomyosarcoma of the inferior vena cava. Vascular. 2015;23(3):329–32.PubMedCrossRef Jiang H, Wang YX, Li B, Jiang YY, Miao C, Li, et al. Surgical management of leiomyosarcoma of the inferior vena cava. Vascular. 2015;23(3):329–32.PubMedCrossRef
9.
go back to reference Dew J, Hansen K, Hammon J, McCoy T, Levine EA, Shen P. Leiomyosarcoma of the inferior vena cava: surgical management and clinical results. In: American Surgeon; 2005. p. 497–501. Dew J, Hansen K, Hammon J, McCoy T, Levine EA, Shen P. Leiomyosarcoma of the inferior vena cava: surgical management and clinical results. In: American Surgeon; 2005. p. 497–501.
10.
go back to reference Cananzi FCM, Mussi C, Bordoni MG, Marrari A, De Sanctis R, Colombo P, et al. Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava. J Surg Oncol. 2016;114(1):44–9.PubMedCrossRef Cananzi FCM, Mussi C, Bordoni MG, Marrari A, De Sanctis R, Colombo P, et al. Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava. J Surg Oncol. 2016;114(1):44–9.PubMedCrossRef
Metadata
Title
Extra Luminal Leiomyosarcoma of Inferior Venacava: a Hepatobiliary Surgeon Perspective
Authors
Narendra Pandit
Laligen Awale
Tek Narayan Yadav
Lokesh Shekher Jaiswal
Shailesh Adhikary
Publication date
01-06-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2020
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00351-5

Other articles of this Issue 2/2020

Journal of Gastrointestinal Cancer 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.